Home World News FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung... World News FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung Cancer By Ogkologos - January 22, 2026 500 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the DeLLphi-304 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Ivonescimab Plus Chemotherapy Significantly Improves PFS in Patients with NSCLC Previously... June 19, 2024 EMA Recommends Granting a Marketing Authorisation for Elinzanetant September 26, 2025 Determination of the Incidence of Driver Mutations in Patients with NSCLC... March 24, 2021 Abiraterone Acetate Plus Prednisone and LHRH Analogue is Active and Safe... October 4, 2021 Load more HOT NEWS Study Reinforces Treatment Idea for Cancer with Microsatellite Instability Breaking News: Medical Debt and Your Credit Report Cancer Screening Guidelines Often Lack Information on Potential Harms, Study Finds ctDNA Monitoring Improves Early Relapse Detection After Treatment with Axicabtagene Ciloleucel...